Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Clevidipine in the Postoperative Treatment of Hypertension Assessing Safety Events (With Nicardipine as Active Comparator) (ECLIPSE-NIC)

NCT00093925 is registered in ClinicalTrials.gov with The Medicines Company as lead sponsor.

NCT NCT00093925
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00093925 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Clevidipine in the Postoperative Treatment of Hypertension Assessing Safety Events (With Nicardipine as Active Comparator) (ECLIPSE-NIC)
Lead sponsor
The Medicines Company
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2004
Completion date
September 30, 2006
Enrollment
739 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension